Skip to main content
Top
Published in: BMC Surgery 1/2022

Open Access 01-12-2022 | Subtotal Gastrectomy | Research

Near infrared ray-guided surgery using Firefly technology of the daVinci Xi system and intraoperative upper gastrointestinal endoscopy for subtotal gastrectomy and surgery for cancer of the gastroesophageal junction

Authors: Hiroyuki Sagawa, Masaki Saito, Sunao Ito, Shunsuke Hayakawa, Shohei Ueno, Tomotaka Okubo, Tatsuya Tanaka, Ryo Ogawa, Hiroki Takahashi, Yoichi Matsuo, Akira Mitsui, Masahiro Kimura, Shuji Takiguchi

Published in: BMC Surgery | Issue 1/2022

Login to get access

Abstract

Background

In gastrectomies, especially subtotal gastrectomies and operations on the gastroesophageal junction, identifying the exact location of the tumor and establishing the appropriate resection line is very important. Accurate resection lines have a major impact on the preservation of organ function and curability. Preservation of as much as possible of the remaining stomach, including the fornix, may be an important surgical goal for maintaining an adequate postoperative quality of life. In adenocarcinoma of the gastroesophageal junction, the height of the esophageal dissection may affect reconstruction of the transhiatal approach.

Methods

We perform a new technique, near infrared ray-guided surgery, for the accurate localization of a tumor using the Firefly technology of the daVinci Xi system and intra-operative upper gastrointestinal endoscopy. We used this new technique for cases of upper gastric cancer or adenocarcinoma of the gastroesophageal junction. In this retrospective study, we examined to determine the extent (mm) of the tumor invasion of the esophagus, visualization of near infrared ray contained within endoscopic light, and distance from the proximal margin of the tumor to the surgical cut line on rapid histopathology and in the permanent preparation, including the operative videos and extracted specimens.

Results

We performed near infrared ray-guided surgery for 12 patients with gastric cancer or adenocarcinoma of the gastroesophageal junction, and the near infrared ray was clearly seen as green light with Firefly mode in all the patients. Near infrared ray-guided surgery was useful for obtaining localization of the tumor. In addition, it was possible to resect organ with adequate margins from tumor. Rapid intraoperative histopathological examinations confirmed that the resected specimens had negative margins. None of the patients required additional resection.

Conclusions

We believe that because near infrared ray-guided surgery can provide an accurate resection line, it will be useful for the resection of upper gastric cancer and adenocarcinoma of the gastroesophageal junction. It will also provide patients with a good postoperative quality of life after surgery.
Literature
1.
go back to reference Nakauchi M, Suda K, Nakamura K, Shibasaki S, Kikuchi K, Nakamura T, et al. Laparoscopic subtotal gastrectomy for advanced gastric cancer: technical aspects and surgical, nutritional and oncological outcomes. Surg Endosc. 2017;31(11):4631–40.CrossRef Nakauchi M, Suda K, Nakamura K, Shibasaki S, Kikuchi K, Nakamura T, et al. Laparoscopic subtotal gastrectomy for advanced gastric cancer: technical aspects and surgical, nutritional and oncological outcomes. Surg Endosc. 2017;31(11):4631–40.CrossRef
2.
go back to reference Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRef Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRef
3.
go back to reference Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.CrossRef Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.CrossRef
4.
go back to reference Leite-Moreira AF, Soares J-B. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today. 2007;12:276–88.CrossRef Leite-Moreira AF, Soares J-B. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today. 2007;12:276–88.CrossRef
5.
go back to reference Takiguchi S, Takata A, Murakami K, Miyazaki Y, Yanagimoto Y, Kurokawa Y, et al. Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2014;17(2):200–5.CrossRef Takiguchi S, Takata A, Murakami K, Miyazaki Y, Yanagimoto Y, Kurokawa Y, et al. Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2014;17(2):200–5.CrossRef
6.
go back to reference Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409(6817):194–8.CrossRef Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409(6817):194–8.CrossRef
7.
go back to reference Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(2832–6):25. Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(2832–6):25.
8.
go back to reference Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.CrossRef Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.CrossRef
9.
go back to reference Wu R, Dong W, Zhou M, Zhang F, Marini CP, Ravikumar TS, et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med. 2007;176:805–13.CrossRef Wu R, Dong W, Zhou M, Zhang F, Marini CP, Ravikumar TS, et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med. 2007;176:805–13.CrossRef
10.
go back to reference Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappa B activation in human endothelial cells. Circulation. 2004;109:2221–6.CrossRef Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappa B activation in human endothelial cells. Circulation. 2004;109:2221–6.CrossRef
11.
go back to reference Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery. 2008;143:334–42.CrossRef Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery. 2008;143:334–42.CrossRef
12.
go back to reference Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study. Ann Surg. 2019;274:120.CrossRef Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study. Ann Surg. 2019;274:120.CrossRef
13.
go back to reference Goto H, Kanaji S, Otsubo D, Oshikiri T, Yamamoto M, Nakamura T, et al. Comparison of total versus subtotal gastrectomy for remnant gastric cancer. Langenbecks Arch Surg. 2019;404(6):753–60.CrossRef Goto H, Kanaji S, Otsubo D, Oshikiri T, Yamamoto M, Nakamura T, et al. Comparison of total versus subtotal gastrectomy for remnant gastric cancer. Langenbecks Arch Surg. 2019;404(6):753–60.CrossRef
14.
go back to reference Furukawa H, Kurokawa Y, Takiguchi S, Tanaka K, Miyazaki Y, Makino T, et al. Short-term outcomes and nutritional status after laparoscopic subtotal gastrectomy with a very small remnant stomach for cStage I proximal gastric carcinoma. Gastric Cancer. 2018;21(3):500–7.CrossRef Furukawa H, Kurokawa Y, Takiguchi S, Tanaka K, Miyazaki Y, Makino T, et al. Short-term outcomes and nutritional status after laparoscopic subtotal gastrectomy with a very small remnant stomach for cStage I proximal gastric carcinoma. Gastric Cancer. 2018;21(3):500–7.CrossRef
15.
go back to reference Peeters TL. Ghrelin: a new player in the control of gastrointestinal functions. Gut. 2005;54(11):1638–49.CrossRef Peeters TL. Ghrelin: a new player in the control of gastrointestinal functions. Gut. 2005;54(11):1638–49.CrossRef
16.
go back to reference Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun. 2001;280(3):904–7.CrossRef Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun. 2001;280(3):904–7.CrossRef
17.
go back to reference Takachi Ko, Doki Y, Ishikawa O, Miyashiro I, Sasaki Yo, Ohigashi H, et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res. 2006;130(1):1–7.CrossRef Takachi Ko, Doki Y, Ishikawa O, Miyashiro I, Sasaki Yo, Ohigashi H, et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res. 2006;130(1):1–7.CrossRef
18.
go back to reference Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138(4):1312–20.CrossRef Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138(4):1312–20.CrossRef
19.
go back to reference Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcarsia: a randomized controlled trial. Lancet Oncol. 2006;7:644–51.CrossRef Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcarsia: a randomized controlled trial. Lancet Oncol. 2006;7:644–51.CrossRef
20.
go back to reference Takahashi H, Yanagita TE, Suzuki T, Maeda A, Nakai N, Maeda Y, et al. Accurate localization of rectal cancer using near infrared ray-guided surgery with intra-operative colonoscopy and da Vinci Firefly technology. Surg Today. 2020;50(2):205–8.CrossRef Takahashi H, Yanagita TE, Suzuki T, Maeda A, Nakai N, Maeda Y, et al. Accurate localization of rectal cancer using near infrared ray-guided surgery with intra-operative colonoscopy and da Vinci Firefly technology. Surg Today. 2020;50(2):205–8.CrossRef
Metadata
Title
Near infrared ray-guided surgery using Firefly technology of the daVinci Xi system and intraoperative upper gastrointestinal endoscopy for subtotal gastrectomy and surgery for cancer of the gastroesophageal junction
Authors
Hiroyuki Sagawa
Masaki Saito
Sunao Ito
Shunsuke Hayakawa
Shohei Ueno
Tomotaka Okubo
Tatsuya Tanaka
Ryo Ogawa
Hiroki Takahashi
Yoichi Matsuo
Akira Mitsui
Masahiro Kimura
Shuji Takiguchi
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2022
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-022-01633-9

Other articles of this Issue 1/2022

BMC Surgery 1/2022 Go to the issue